Rise of clinical studies in the field of machine learning: A review of data registered in clinicaltrials.gov

Abstract

Although advances in machine-learning healthcare applications promise great potential for innovative medical care, few data are available on the translational status of these new technol-ogies. We aimed to provide a comprehensive characterization of the development and status quo of clinical studies in the field of machine learning. For this purpose, we performed a registry-based analysis of machine-learning-related studies that were published and first available in the Clinical-Trials.gov database until 2020, using the database’s study classification. In total, n = 358 eligible studies could be included in the analysis. Of these, 82% were initiated by academic institutions/uni-versity (hospitals) and 18% by industry sponsors. A total of 96% were national and 4% international. About half of the studies (47%) had at least one recruiting location in a country in North America, followed by Europe (37%) and Asia (15%). Most of the studies reported were initiated in the medical field of imaging (12%), followed by cardiology, psychiatry, anesthesia/intensive care medicine (all 11%) and neurology (10%). Although the majority of the clinical studies were still initiated in an academic research context, the first industry-financed projects on machine-learning-based algorithms are becoming visible. The number of clinical studies with machine-learning-related applications and the variety of medical challenges addressed serve to indicate their increasing importance in future clinical care. Finally, they also set a time frame for the adjustment of medical device-related regulation and governance.